Rapid RWD Analyses to Support Safety Signal Assessments

This webinar recording is a presentation and panel discussion about the overview of the background and methodology for the Rapid Signal Assessment Using Real World Date Initiative, an analysis of the two recently released solutions, and an outline of upcoming plans for the initiative.
Panelists include:
Vaishali Patadia, Head of Signal Management and Risk Management in Global Patient Safety, Amgen
Claudia Salinas, Senior Director of Pharmacoepidemiology, Eli Lilly and Company
Lu Wang, Director of Global Epidemiology, Johnson & Johnson
Katie Miller, Principal Scientific Enablement Director, Genentech